.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Start-up Alimera Sciences receives funding for ophthalmic products

August 4, 2004

Series A financing worth $26.75 million will be used by Alimera Sciences Inc. for acquisition and continued development of the company's ophthalmic pharmaceutical pipeline, along with commercialization of the company's over-the-counter ophthalmic products.